Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Proof-of-Concept Study of CelluJuve® for the Treatment of Moderate to Severe Nasolabial Folds

NCT07545980 is registered in ClinicalTrials.gov with Spiderwort Biotechnologies Inc. as lead sponsor.

NCT NCT07545980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07545980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Proof-of-Concept Study of CelluJuve® for the Treatment of Moderate to Severe Nasolabial Folds
Lead sponsor
Spiderwort Biotechnologies Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
April 29, 2026
Completion date
July 31, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasolabial fold wrinkles